3MJ9 image
Deposition Date 2010-04-12
Release Date 2011-02-23
Last Version Date 2024-11-27
Entry Detail
PDB ID:
3MJ9
Keywords:
Title:
Crystal structure of JAML in complex with the stimulatory antibody HL4E10
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
2.95 Å
R-Value Free:
0.28
R-Value Work:
0.22
R-Value Observed:
0.22
Space Group:
P 43 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Junctional adhesion molecule-like
Gene (Uniprot):Jaml
Mutations:K124R, R211Q
Chain IDs:A
Chain Length:268
Number of Molecules:1
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Molecule:STIMULATORY HAMSTER ANTIBODY HL4E10 FAB HEAVY CHAIN
Chain IDs:C (auth: H)
Chain Length:223
Number of Molecules:1
Biological Source:CRICETULUS MIGRATORIUS
Polymer Type:polypeptide(L)
Molecule:STIMULATORY HAMSTER ANTIBODY HL4E10 FAB LIGHT CHAIN
Chain IDs:B (auth: L)
Chain Length:213
Number of Molecules:1
Biological Source:CRICETULUS MIGRATORIUS
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
ASN A ASN GLYCOSYLATION SITE
Ligand Molecules
Primary Citation
Molecular insights into gamma delta T cell costimulation by an anti-JAML antibody.
Structure 19 80 89 (2011)
PMID: 21220118 DOI: 10.1016/j.str.2010.10.007

Abstact

γδ T cells bridge innate and adaptive immunity and function in immunosurveillance, immunoregulation, tumor cell recognition, and as first line of defense against microbial infection. Costimulation of epithelial γδ T cell activation by the JAML receptor can be induced by interaction with its endogenous ligand CAR or by binding of the stimulatory antibody HL4E10. We, therefore, determined the crystal structure of the JAML-HL4E10 Fab complex at 2.95 Å resolution. HL4E10 binds the membrane-proximal domain of JAML through hydrophobic interactions that account for nanomolar affinity and long half-life, contrasting with the fast kinetics and micromolar affinity of the hydrophilic CAR interaction with the membrane-distal JAML domain. Thus, despite different binding sites and mechanisms, JAML interaction with these two disparate ligands leads to the same functional outcome, namely JAML triggering and induction of cell signaling. Several characteristics of the HL4E10 antibody might then be harnessed in therapeutic applications, such as promoting healing of acute or chronic wounds.

Legend

Protein

Chemical

Disease

Primary Citation of related structures